Imaging agent: Difference between revisions
m Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +) |
No edit summary |
||
| Line 10: | Line 10: | ||
*[[Nanoparticle]] | *[[Nanoparticle]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Latest revision as of 01:31, 24 August 2015
|
WikiDoc Resources for Imaging agent |
|
Articles |
|---|
|
Most recent articles on Imaging agent Most cited articles on Imaging agent |
|
Media |
|
Powerpoint slides on Imaging agent |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Imaging agent at Clinical Trials.gov Trial results on Imaging agent Clinical Trials on Imaging agent at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Imaging agent NICE Guidance on Imaging agent
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Imaging agent Discussion groups on Imaging agent Patient Handouts on Imaging agent Directions to Hospitals Treating Imaging agent Risk calculators and risk factors for Imaging agent
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Imaging agent |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Overview
Imaging agents are chemicals designed to allow clinicians to determine whether a mass is benign or malignant and locate metastatic cancer sites in the body.
The development of an imaging agent involves synthesizing the agent to target a particular tumor or process, after which the imaging instruments can be adjusted to neutralize the target. Such agents are first examined via preclinical animal studies before engaging in early-phase human clinical studies.